跳至主要内容
临床试验/NCT00437151
NCT00437151已完成4 期

An Analysis of Adherence and Associated Factors in Subjects Undergoing Differin® Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris.

Galderma R&D2 个研究点 分布在 1 个国家目标入组 61 人开始时间: 2006年6月最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
Galderma R&D
入组人数
61
试验地点
2
主要终点
Efficacy - Percent adherence calculated from MEMS Caps readings

研究概览

简要总结

The primary objective of this study is to investigate potential differences in treatment adherence by teenagers among four interventions during treatment for acne.

详细描述

Same as above.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
13 Years 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Adolescent subjects with a diagnosis of moderate to severe Acne vulgaris

排除标准

  • Subjects with acne conglobata, acne fulminans, secondary acne (chloracne, drug-induced acne, etc.), or severe acne requiring more than topical treatment (e.g. oral isotretinoin)

结局指标

主要结局

Efficacy - Percent adherence calculated from MEMS Caps readings

时间窗: 12 weeks

次要结局

  • Efficacy - lesion counts; percent adherence as calculated by product weights and by Subject's Diary; Global Severity Assessment; Global Assessment of Improvement; Subject questionnaire(12 weeks)
  • Safety - tolerability and adverse event reporting(12 weeks)

研究者

发起方
Galderma R&D
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验